Literature DB >> 21501160

Increased sensitivity to antigen in high avidity CD8(+) T cells results from augmented membrane proximal T-cell receptor signal transduction.

Sharad K Sharma1, Martha A Alexander-Miller.   

Abstract

The functional avidity of a cytotoxic T lymphocyte (CTL) is known to be a critical determinant of the efficacy with which it clears pathogens. High avidity cells, which are by definition highly sensitive to peptide antigen, are superior for elimination of viruses and tumours. Our studies have established the ability of T cells to undergo avidity modulation as a result of antigen encounter. High and low avidity cells established in this manner exhibit significant differences in the amount of peptide required to elicit effector function. However, how signalling is regulated in these cells as it relates to the control of peptide sensitivity remains to be defined. To address this question, we compared T-cell receptor (TCR) signal transduction events in high and low avidity CTL generated from OT-I(rag2-) TCR transgenic mice. Our data suggest that divergent signalling is initiated at the TCR-associated CD3ζ, with low avidity CTL requiring higher amounts of pMHC to achieve threshold levels of phosphorylated CD3ζ compared with high avidity CTL. Further, this difference is transduced further downstream to mitogen-activated protein kinase and Ca(2+) signalling pathways. These results suggest that regulated control of the initiation of TCR signalling in high versus low avidity cells determines the amount of peptide required for T-cell activation.
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501160      PMCID: PMC3112340          DOI: 10.1111/j.1365-2567.2011.03440.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  48 in total

Review 1.  Calcium signaling mechanisms in T lymphocytes.

Authors:  R S Lewis
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen.

Authors:  T M Fahmy; J G Bieler; M Edidin; J P Schneck
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

3.  Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR.

Authors:  T M Lawson; S Man; E C Wang; S Williams; N Amos; G M Gillespie; P A Moss; L K Borysiewicz
Journal:  Int Immunol       Date:  2001-11       Impact factor: 4.823

4.  Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR.

Authors:  M K Slifka; J L Whitton
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 5.  Proximal protein tyrosine kinases in immunoreceptor signaling.

Authors:  S Latour; A Veillette
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

6.  Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo.

Authors:  M Li; G M Davey; R M Sutherland; C Kurts; A M Lew; C Hirst; F R Carbone; W R Heath
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

7.  Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining.

Authors:  M A Derby; J Wang; D H Margulies; J A Berzofsky
Journal:  Int Immunol       Date:  2001-06       Impact factor: 4.823

Review 8.  Self-tolerance and the composition of T cell repertoire.

Authors:  L A Sherman; D J Morgan; C T Nugent; F J Hernandez; H T Kreuwel; A Murtaza; A Ko; J Biggs
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

9.  Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: correlation with CD8alphabeta versus CD8alphaalpha expression.

Authors:  A G Cawthon; H Lu; M A Alexander-Miller
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

10.  Essential role of CD8 palmitoylation in CD8 coreceptor function.

Authors:  A Arcaro; C Grégoire; N Boucheron; S Stotz; E Palmer; B Malissen; I F Luescher
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

View more
  5 in total

1.  High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Authors:  Christoph T Berger; Nicole Frahm; David A Price; Beatriz Mothe; Musie Ghebremichael; Kari L Hartman; Leah M Henry; Jason M Brenchley; Laura E Ruff; Vanessa Venturi; Florencia Pereyra; John Sidney; Alessandro Sette; Daniel C Douek; Bruce D Walker; Daniel E Kaufmann; Christian Brander
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu.

Authors:  Zhidong Hu; Jing Wang; Yanmin Wan; Lingyan Zhu; Xiaonan Ren; Sugan Qiu; Yanqin Ren; Songhua Yuan; Xiangqing Ding; Jian Chen; Chenli Qiu; Jun Sun; Xiaoyan Zhang; Jim Xiang; Chao Qiu; Jianqing Xu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

3.  Immune Signature of Enhanced Functional Avidity CD8+ T Cells in vivo Induced by Vaccinia Vectored Vaccine.

Authors:  Zhidong Hu; Lingyan Zhu; Jing Wang; Yanmin Wan; Songhua Yuan; Jian Chen; Xiangqing Ding; Chenli Qiu; Xiaoyan Zhang; Chao Qiu; Jianqing Xu
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

4.  TCR Dependent Metabolic Programming Regulates Autocrine IL-4 Production Resulting in Self-Tuning of the CD8+ T Cell Activation Setpoint.

Authors:  Kali F Crofts; Beth C Holbrook; David R Soto-Pantoja; David A Ornelles; Martha A Alexander-Miller
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

Review 5.  Functional avidity: a measure to predict the efficacy of effector T cells?

Authors:  Selena Viganò; Daniel T Utzschneider; Matthieu Perreau; Giuseppe Pantaleo; Dietmar Zehn; Alexandre Harari
Journal:  Clin Dev Immunol       Date:  2012-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.